NCT02305277View on ClinicalTrials.gov

Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Parkinson
Interventions
DRUG

BIA 9-1067 (clinical micronized, CM)

DRUG

BIA 9-1067 (to-be-marketed, TBM)

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT02305277 - Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers | Biotech Hunter | Biotech Hunter